Effectiveness of Disease Modifying Anti-Rheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort.,The Journal of Rheumatology

当前位置： X-MOL 学术 › J. Rheumatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Effectiveness of Disease Modifying Anti-Rheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort.
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-06-01 , DOI: 10.3899/jrheum.211231
Ashish J Mathew ₁ , Mitchell Sutton ₂ , Daniel Pereira ₂ , Dafna D Gladman ₃ , Vinod Chandran ₄

Affiliation

A.J. Mathew, DNB, DM, Centre for Prognosis Studies in the Rheumatic Diseases, Psoriatic Arthritis Program, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada, Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada, The Copenhagen Center for Arthritis and Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, and Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India.
M. Sutton, MSc, D. Pereira, MSc, Centre for Prognosis Studies in the Rheumatic Diseases, Psoriatic Arthritis Program, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in the Rheumatic Diseases, Psoriatic Arthritis Program, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Division of Rheumatology, Department of Medicine, University of Toronto, and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
V. Chandran, DM, PhD, FRCPC, Centre for Prognosis Studies in the Rheumatic Diseases, Psoriatic Arthritis Program, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Institute of Medical Science, University of Toronto, Toronto, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Our objective was to assess the effectiveness of conventional and targeted disease modifying anti-rheumatic drugs (cDMARDs and tDMARDs, respectively) in treating enthesitis in PsA.

中文翻译：